Louis P.
- Country
- France
- Department
- Service d'Endocrinologie
Research Overview
- Evaluation of Semaglutide in Glycemic Control for Patients with Type 1 Diabetes and Insulin Resistance: A Randomized, Open-Label Study
- Randomized, Double-Blind, Placebo-Controlled Study of Dapansutrile for Glycemic Control in Type 2 Diabetes Mellitus Patients on Standard Therapy
- Evaluation of Baxdrostat and Dapagliflozin on Heart Failure Incidence and Cardiovascular Mortality in High-Risk Patients: A Phase III Randomized Controlled Trial
Data & Insights
Has run more than one trial at 75 of 649 partner sites.
Specializations
Diabetes Management
This investigator specializes in advanced therapeutic approaches for Type 2 diabetes mellitus, with particular emphasis on innovative treatment combinations and glycemic control optimization.
- Glycemic Control Assessment
- Novel Anti-diabetic Therapies
- Standard-of-Care Integration
The research focus includes evaluating emerging treatments for patients with inadequately controlled diabetes.
Cardiovascular Complications
The investigator explores the intersection of diabetes and cardiovascular health, studying treatments that address both metabolic control and cardiovascular risk factors.
- Cardiovascular Outcomes
- Major Cardiovascular Events
- Risk Management Strategies
Key interests include comparative assessments of diabetes treatments with cardiovascular benefits.
Complex Diabetes Conditions
Expertise extends to treating complex diabetes presentations, including double diabetes and its therapeutic management using advanced treatment modalities.
- Glycemic Target Achievement
- GLP-1 Receptor Agonist Applications
- Combined Therapy Approaches
The focus includes evaluating time-in-range metrics and treatment optimization for complex diabetes cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.